Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (R) Mandelic Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1840671A details a bio-catalytic route for (R)-mandelic acid using Brevibacterium flavum. Offers high optical purity and greener manufacturing for pharmaceutical supply chains.
Patent CN106676140A reveals high-efficiency enzymatic synthesis. Offers supply chain stability and cost reduction for clopidogrel intermediates.
Novel chiral resolving agent enables high-purity (R)-o-chloromandelic acid production. Mature industrial route ensures supply chain stability and cost efficiency for pharmaceutical intermediates.
Patent CN100376681C details a microbial asymmetric reduction method for (R)-mandelic acid using Saccharomyces cerevisiae, offering a green, cost-effective alternative to traditional chemical resolution for pharmaceutical manufacturing.
Patent CN101701222B reveals a robust enzymatic route for (R)-mandelic acid, offering superior purity and scalable manufacturing for global pharmaceutical supply chains.
Novel nitrilase enables efficient production of chiral intermediates for clopidogrel with reduced environmental impact and scalable supply chain solutions.
Patent CN105505904A reveals enhanced nitrilase mutant for high-purity (R)-mandelic acid production with improved selectivity and activity for reliable supply.
Patent CN116848257A enables green production of (R)-mandelic acid. Achieve cost reduction in pharmaceutical intermediates manufacturing with sustainable enzyme cascades.
Patent CN101134943B reveals a novel Alcaligenes strain for >99.9% e.e. mandelic acid. Discover cost-effective biocatalytic solutions for pharmaceutical manufacturing.
Patent CN105755095B details enzymatic synthesis of chiral hydroxy acids. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN100385007C details a microbial method for (R)-mandelic acid using Brevibacterium flavum, offering high optical purity and scalable biocatalysis for pharma intermediates.